secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2021-07-20T23:59:59+00:00
Accession:  0001564590-21-037262
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences appoints Nobel laureate Dr. Michael Houghton to board
--------------------------------------------------------------------------

- Dr. Michael Houghton, 2020 Nobel Prize winner for HCV discovery, joins as independent director.
- Board expands from eight to nine members; Houghton also joins Science and Technology Committee.
- Houghton received an option for 30,000 shares vesting in three equal annual installments.
- He brings 40+ years of virology and drug development experience, focusing on HBV curative therapies.
- CEO John McHutchison expects his expertise to be invaluable for finite HBV therapy approach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000156459021037262/0001564590-21-037262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000156459021037262/asmb-8k_20210719.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-037262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer